777
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Clinical Oncology

The impact of a multi-hospital network on the inequality in odds of receiving resection or ablation for synchronous colorectal liver metastases

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 842-852 | Received 29 Mar 2023, Accepted 04 Jul 2023, Published online: 07 Aug 2023

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
  • Susanne SC, Ito K, Raoof M, et al. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? Curr Probl Surg. 2018;55(9):330–379. doi: 10.1067/j.cpsurg.2018.08.004.
  • Riihimäki M, Hemminki A, Sundquist J, et al. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6:29765. doi: 10.1038/srep29765.
  • Ito K, Govindarajan A, Ito H, et al. Surgical treatment of hepatic colorectal metastasis: evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century. Cancer J. 2010;16(2):103–110. doi: 10.1097/PPO.0b013e3181d7e8e5.
  • Engstrand J, Nilsson H, Strömberg C, et al. Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer. 2018;18(1):78–89. doi: 10.1186/s12885-017-3925-x.
  • Birrer DL, Tschuor C, Reiner CS, et al. Multimodal treatment strategies for colorectal. Swiss Med Wkly. 2021;151:w20390. doi: 10.4414/smw.2021.20390.
  • Petrelli F, Comito T, Barni S, et al. Stereotactic body radiotherapy for colorectal cancer liver metastases: a systematic review. Radiother Oncol. 2018;129(3):427–434. doi: 10.1016/j.radonc.2018.06.035.
  • Lee J, Shin I-S, Yoon WS, et al. Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: meta-analyses and a systematic review. Radiother Oncol. 2020;145:63–70. doi: 10.1016/j.radonc.2019.12.004.
  • Lam-Boer J ,Al Ali C, Verhoeven RH, et al. Large variation in the utilization of liver resections in stage IV colorectal cancer patients with metastases confined to the liver. Eur J Surg Oncol. 2015;41(9):1217–1225.
  • Pawlik TM, Abdalla EK, Ellis LM, et al. Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg. 2006;10(2):240–248. doi: 10.1016/j.gassur.2005.07.027.
  • Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128–1137. doi: 10.1056/NEJMsa012337.
  • Ho V, Heslin MJ, Yun H, et al. Trends in hospital and surgeon volume and operative mortality for cancer surgery. Ann Surg Oncol. 2006;13(6):851–858. doi: 10.1245/ASO.2006.07.021.
  • Stitzenberg KB, Meropol NJ. Trends in centralization of cancer surgery. Ann Surg Oncol. 2010; 17(11):2824–2831. doi: 10.1245/s10434-010-1159-0.
  • Torzilli G, Viganò L, Giuliante F, et al. Liver surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it. Updates Surg. 2016;68(2):135–142. doi: 10.1007/s13304-016-0373-0.
  • Vallance AE, VanderMeulen J, Kuryba A, et al. Impact of hepatobiliary service centralization on treatment and outcomes in patients with colorectal cancer and liver metastases. Br J Surg. 2017;104(7):918–925. doi: 10.1002/bjs.10501.
  • Weledji EP. Centralization of liver cancer surgery and impact on multidisciplinary teams working on stage IV colorectal cancer. Oncol Rev. 2017;11(2):331. doi: 10.4081/oncol.2017.331.
  • Huguet M. Centralization of care in high volume hospitals and inequalities in access to care. Social Science & Medicine. 2020;260:113177. doi: 10.1016/j.socscimed.2020.113177.
  • Cadilhac DA, Moodie ML, Lalor EE, et al. Improving access to evidence-based acute stroke services: development and evaluation of a health system model to address equity of access issues. Aust Health Review. 2006;30(1):109–118. doi: 10.1071/AH060109.
  • Addicott R, McGivern G, Ferlie E. The distortion of a managerial technique? The case of clinical networks in UK health care. Br J Management. 2007;18(1):93–105. doi: 10.1111/j.1467-8551.2006.00494.x.
  • Balkundi P, Harrison DA. Ties, leaders, and time in teams: strong inference about network structure’s effects on team viability and performance. AMJ. 2006;49(1):49–68. doi: 10.5465/amj.2006.20785500.
  • Inkpen AC, Tsang EWK. Social capital, networks, and knowledge transfer. AMR. 2005;30(1):146–165. doi: 10.5465/amr.2005.15281445.
  • Koka BR, Prescott JE. Strategic alliances as social capital: a multidimensional view. Strat Mgmt J. 2002;23(9):795–816. doi: 10.1002/smj.252.
  • Nolte E, Pitchforth E, Miani C. The changing hospital landscape: an exploration of international experiences. RAND Health Quarterly. 2014;4(3):14–20.
  • Van de Voorde C, Van den Heede K, Beguin C, et al. Required hospital capacity in 2025 and criteria for rationalisation of complex cancer surgery, radiotherapy and maternity services. Brussels: Federatie Kennisgeving voor de Gezondheidszorg; 2017.
  • Netherlands Comprehensive Cancer Organisation, Citrienprogramma Naar regionale oncologienetwerken, Dutch Federation of Cancer Patient Organisations & SONCOS Federation of Medical Specialists, on behalf of Taskforce Oncologie. Regionale Oncologienetwerken in Beeld [Internet]. 2022 [cited 2023 Apr]. Available from: https://oncologienetwerken.nl/sites/default/files/2022-04/Rapport_Oncologienetwerken-in-beeld_2022-april_1.pdf
  • Kelaher M, Sabanovic H, La Brooy C, et al. Does more equitable governance lead to more equitable health care? A case study based on the implementation of health reform in aboriginal health Australia. Soc Sci Med. 2014;123:278–286. doi: 10.1016/j.socscimed.2014.07.032.
  • Bambra C, Garthwaite K, Hunter D. All things being equal: does it matter for equity how you organize and pay for health care? A review of the international evidence. Int J Health Serv. 2014;44(3):457–477. doi: 10.2190/HS.44.3.c.
  • Kroneman M, Boerma W, van den Berg M, et al. The Netherlands health system review. 2nd ed. Health Syst Trans. 2016;18:1–240.
  • Foundation For Oncological Cooperation (SONCOS). Multidisciplinary standards for oncological are in the Netherlands. 2021.
  • Nederlandse Vereniging voor Heelkunde (NVvH). Normering Chirurgische Behandeling v1.0. 2011.
  • Kolfschoten NE, Marang van de Mheen PJ, Gooiker GA, et al. Variation in case-mix between hospitals treating colorectal cancer patients in The Netherlands. Eur J Surg Oncol. 2011;37(11):956–963. doi: 10.1016/j.ejso.2011.08.137.
  • Oncologisch Netwerk Zuidoost-Nederland. OncoZON [Internet]. 2017 [updated 2020 Dec 3]. Available from. https://www.oncozon.nl/.
  • Netherlands Comprehensive Cancer Organisation (IKNL). Netherlands Cancer. Registry (NCR). Available from https://iknl.nl/en/ncr.
  • Fritz A, Percy C, Jack A, et al. International classification of diseases for oncology (ICD-O). 3rd ed. 1st revision. Geneva: World Health Organisation. [Internet]. 2013. Available from: https://apps.who.int/iris/handle/10665/42344
  • Sobin LH, Gospodarowicz MK, Wittekind CH, Union for International Cancer Control (UICC). The TNM classification of malignant tumours. 7th ed. Chichester: Wiley-Blackwell; 2009.
  • Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics. 1997;53(3):983–997. doi: 10.2307/2533558.
  • G KM, H RJ. An improved approximation to the precision of fixed effects from restricted maximum likelihood. Computat Statist Data Anal. 2009;53:2583–2595.
  • Tiernan J, Briggs CD, Irving GRB, et al. Evaluation of the introduction of a standardised protocol for the staging and follow-up of colorectal cancer on resection rates for liver metastases. Ann R Coll Surg Engl. 2010;92(3):225–230. doi: 10.1308/003588410X12628812458419.
  • Breekveldt ECH, Lansdorp-Vogelaar I, Toes-Zoutendijk E, et al. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in The Netherlands: a population-based study. Lancet Gastroenterol Hepatol. 2022;7(1):60–68. doi: 10.1016/S2468-1253(21)00368-X.
  • Dinmohamed AG, Visser O, Verhoeven RHA, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020;21(6):750–751. doi: 10.1016/S1470-2045(20)30265-5.
  • Fields AC, Lu PW, Yoo J, et al. Treatment of stage I-III rectal cancer: who is refusing surgery? J Surg Oncol. 2020;121(6):990–1000. doi: 10.1002/jso.25873.
  • Rahouma M, Harrison S, Kamel M, et al. Consequences of refusing surgery for esophageal cancer: a national cancer database analysis. Ann Thorac Surg. 2018;106(5):1476–1483. doi: 10.1016/j.athoracsur.2018.06.030.
  • Coffman A, Torgeson A, Lloyd SC. Correlates of refusal of surgery in the treatment of non-metastatic pancreatic adenocarcinoma. Ann Surg Oncol. 2019;26(1):98–108. doi: 10.1245/s10434-018-6708-y.
  • Pines JM, Strong A. Cognitive biases in emergency physicians: a pilot study. J Emerg Med. 2019;57(2):168–172. doi: 10.1016/j.jemermed.2019.03.048.
  • Kongstvedt PR. Essentials of managed health care. (4th edition). Sudbury, Massachusetts: Jones and Bartlett Publishers; 2000. (Chapter 19: physician Behavior Change in Managed Health Care).
  • Davis R, Campbell R, Hildon Z, et al. Theories of behaviour and behaviour change across the social and behavioural sciences: a scoping review. Health Psychol Rev. 2015;9(3):323–344. doi: 10.1080/17437199.2014.941722.
  • Reinertsen JL. Algorithms, guidelines, and protocols: can they really improve what we do? Transfusion. 1994;34(4):281–282. doi: 10.1046/j.1537-2995.1994.34494233573.x.
  • Henderson J, Valenti LA, Britt HC, et al. Estimating non-billable time in Australian general practice. Med J Aust. 2016;205(2):79–83. doi: 10.5694/mja16.00287.
  • Gebhardt B, Rajagopalan M, Gill B, et al. Impact of dynamic changes to a bone metastases pathway in a large, integrated, national cancer institute-designated comprehensive cancer center network. Pract Radiat Oncol. 2015;5(6):398–405. doi: 10.1016/j.prro.2015.06.013.
  • Cabana MD, Rand CS, Powe NR, et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458–1465. doi: 10.1001/jama.282.15.1458.
  • Mekenkamp LJM, Koopman M, Teerenstra S, et al. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. Br J Cancer. 2010;103(2):159–164. doi: 10.1038/sj.bjc.6605737.
  • Punt CJA, Swijnenburg RJ, van Grieken NCT, et al. Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases CAIRO5 a randomised phase 3 study of the Dutch Colorectal Cancer Group (DCCG) – study protocol v12 [Study protocol]. 2022 Feb 17. Available from: https://dccg.nl/trial/cairo5
  • Wang M, Dolovich L, Holbrook A, et al. Factors that influence community hospital involvement in clinical trials: a qualitative discriptive study. J Eval Clin Pract. 2022;28(1):79–85. doi: 10.1111/jep.13583.